{"id":"W4386084010","doi":"10.1080/14740338.2023.2247976","title":"An update on the safety of long-term vedolizumab use in inflammatory bowel disease","year":2023,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre","funders":"Allergan; Biogen; Pfizer; Amgen","keywords":"Vedolizumab; Medicine; Inflammatory bowel disease; Ulcerative colitis; Pouchitis; Clinical trial; Internal medicine; Crohn's disease; Disease; Intensive care medicine; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009153372,0.0006058378,0.001392182,0.0004642136,0.0001246628,0.00002649916,0.0005665313,0.0003004442,0.0002801808],"category_scores_gemma":[0.0008730985,0.0003835508,0.0005647959,0.0004349653,0.000197515,0.0001878113,0.0001054031,0.0008719998,0.0003296208],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004346476,"about_ca_system_score_gemma":0.001154165,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002201939,"about_ca_topic_score_gemma":0.000008734925,"domain_scores_codex":[0.9958677,0.0007786895,0.001419825,0.0006911298,0.0007798673,0.0004627603],"domain_scores_gemma":[0.9958118,0.0009166817,0.0006206507,0.002020812,0.00007108278,0.00055893],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002321059,0.001037749,0.000769312,0.01151563,0.0003405263,0.0002372523,0.001177665,0.00001714199,8.31594e-7,0.004159062,0.01043151,0.9679922],"study_design_scores_gemma":[0.001402403,0.0001268504,0.02671266,0.1143468,0.00006598578,0.00001517759,0.00004781592,0.00002645925,0.000004504994,0.00001323292,0.856837,0.0004011794],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001578099,0.9924841,0.00002649567,0.002136532,0.001443451,0.002802496,0.0003797741,0.000187887,0.0003814877],"genre_scores_gemma":[0.0006353818,0.9952104,0.00001202597,0.0009797794,0.0005701448,0.0003044913,0.00173309,0.0001307278,0.0004239283],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9675911,"threshold_uncertainty_score":0.9998617,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0758371502196532,"score_gpt":0.3884208003101157,"score_spread":0.3125836500904625,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}